Hypersecretion of Gastric Inhibitory Polypeptide Following Oral Glucose in Diabetes Mellitus
The DOI matches its Crossref record.
Abstract
Gastric inhibitory polypeptide (GIP) is insulinotropic and is released after ingestion of glucose in normal man. Changes in plasma immunoreactive gastric inhibitory polypeptide (IRGIP) were therefore studied during a 50-gm. oral glucose tolerance test in 10 normal subjects and 20 subjects with maturity-onset diabetes mellitus. The diabetics were nonobese and treated by diet alone; they exhibited exaggerated increments of plasma IRGIP in association with delayed and diminished peak increases in plasma immunoreactive insulin, suggesting relative failure of the beta-cell response to GIP. The diabetic subjects also showed a paradoxk rise in mean plasma immunoreactive glucagon, with a peak coinciding with that of plasma IRGIP. It is suggested that the defective beta-cell response may lead to diminished feedback inhibition of GIP secretion by insulin in diabetes mellitus and that the glucagonotropic action of GIP may be expressed under these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Reduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307
“Of the known hormones with incretin activity, gastric inhibitory polypeptide (GIP) release after oral glucose and test meals has been studied and found to be increased [11-15] or unchanged [16, 17] in Type 2 diabetic patients as compared to control subjects.”
BackgroundResultThe role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“…have been used over the years, most studies seem to agree that the secretion of GIP is normal or even higher in patients with T2DM compared with healthy control subjects (Crockett et al., 1976; Ross et al., 1977; Ebert and Creutzfeldt, 1980; Jones et al., 1989; Vilsbøll et al., 2001).”
BackgroundResultGIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Y., Fukushima, M., & Yabe, D. (2010) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00022.x · Cited by 746
Creutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731
Metadata
- Authors
- Ross, S. A., Brown, J. C., & Dupré, J.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1977-06-01
- Volume
- 26
- Issue
- 6
- Pages
- 525-529
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2101425299
- Cited by
- 135
- References
- 0
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypersecretion of Gastric Inhibitory Polypeptide Following Oral Glucose in Diabetes Mellitus. https://app.cochat.ai/papers/10.2337/diab.26.6.525
- The paper
- Ross, S. A., Brown, J. C., & Dupré, J. (1977). Hypersecretion of Gastric Inhibitory Polypeptide Following Oral Glucose in Diabetes Mellitus. Diabetes. https://doi.org/10.2337/diab.26.6.525
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.